News Detail
Mumbai, 31 Jan 2024: Glenmark Pharmaceuticals Ltd. and its subsidiary, Ichnos Sciences Inc. on Tuesday said that they have launched a collaborative effort named Ichnos Glenmark Innovation (IGI) to expedite the development of new cancer treatments.
Th......
View Details
Source : Business Today
Glenmark Pharmaceuticals Ltd
Ichnos Sciences Inc
Ichnos Glenmark Innovation
cancer treatments
collaboration
small molecule research
novel biologics
orphan drug designation
U.S. FDA
autoimmune disease assets
hematological malignancies
solid tumors
oncology molecules
clinical trials
multiple myeloma
acute myeloid leukemia
drug discovery
ISB 1442
ISB 2001
GRC 54276
ISB 880
ISB 830 Telazorlimab
advanced therapies
shareholder value
drug development
New York City
Lausanne Switzerland
Mumbai India
biotech companies
academic entities
Related News
- NPPA fixes retail price of 42 formulations, revise prices based on review orders (11-02-2025)
- DCGI calls for focused interventions to enhance drug quality (11-02-2025)
- NPPA asks retailers, dealers and online pharmacies to ensure compliance of Para 24 and 25 of DPCO, 2013 (11-02-2025)
- Kerala: 12 establishments caught selling fake cosmetics, including soaps and creams, with harmful chemicals (11-02-2025)
- EMA establishes regular procedure for scientific advice on certain high-risk medical devices (11-02-2025)
- Goyal urges the pharmaceutical industry to expose those engaged in sale of counterfeit products (11-02-2025)
- WHO identifies research priorities for boosting fight against antimicrobial resistance (11-02-2025)
- Supreme Court Calls on State Officials to Address Misleading Drug Advertisements (10-02-2025)
- Cases will be initiated immediately against individuals involved in sale of intoxicants and adulteration of drugs (10-02-2025)
- An index to gauge states for drug enforcement, improve drug quality (10-02-2025)